Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis
Authors
Keywords
-
Journal
Colorectal Disease
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-31
DOI
10.1111/codi.14994
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon
- (2019) Matthew Skancke et al. DISEASES OF THE COLON & RECTUM
- Overuse and limited benefit of chemotherapy for stage II colon cancer in young patients
- (2019) Richard T. Birkett et al. Clinical Colorectal Cancer
- High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal
- (2018) Blake D. Babcock et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic impact of interhospital variation in adjuvant chemotherapy for patients with Stage II/III colorectal cancer: a nationwide study
- (2018) K. Arakawa et al. Colorectal Disease
- 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
- (2018) Timothy J Iveson et al. LANCET ONCOLOGY
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colon cancer with perforation
- (2018) Kensuke Otani et al. SURGERY TODAY
- Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study
- (2018) Mehmet Artac et al. TUMORI
- Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
- (2017) Masoud Babaei et al. INTERNATIONAL JOURNAL OF CANCER
- Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis
- (2017) Aslam Ejaz et al. JOURNAL OF SURGICAL RESEARCH
- Outcome of colon cancer initially presenting as colon perforation and obstruction
- (2017) Tsung-Ming Chen et al. World Journal of Surgical Oncology
- Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data
- (2017) Min Ki Kim et al. Cancer Research and Treatment
- Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer
- (2016) Leigh Casadaban et al. CANCER
- Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy
- (2016) Jonathan M. Loree et al. Clinical Colorectal Cancer
- Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
- (2016) S.R. Verhoeff et al. INTERNATIONAL JOURNAL OF CANCER
- Postoperative recurrence and risk factors of colorectal cancer perforation
- (2016) Hiroshi Asano et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors
- (2016) Gianpiero Gravante et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Systematic review of prognostic importance of extramural venous invasion in rectal cancer
- (2016) Manish Chand WORLD JOURNAL OF GASTROENTEROLOGY
- A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers
- (2016) Yang Han et al. Scientific Reports
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
- (2016) Lizhen Zhu et al. PLoS One
- Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
- (2015) Andreas Teufel et al. BMC CANCER
- Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up
- (2015) Cari Lewis et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy for colorectal cancer in the elderly
- (2015) Jung Han Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- (2014) Camilla Böckelman et al. ACTA ONCOLOGICA
- A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
- (2014) Elinor Bexe Lindskog et al. BMC CANCER
- Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer
- (2014) Aalok Kumar et al. CANCER
- The role of adjuvant chemotherapy in stage II colorectal cancer patients
- (2014) Hung-Hsin Lin et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- Identification of Risk Factors for Recurrence in High-Risk Stage II Colon Cancer
- (2013) Satoshi Hatano et al. INTERNATIONAL SURGERY
- Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: The Role of Chemotherapy, a Multicentric Retrospective Analysis
- (2013) Roberta Grande et al. PLoS One
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
- (2012) Christophe Tournigand et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Postoperative Adjuvant Chemotherapy for Stage II Colorectal Cancer: A Systematic Review of 12 Randomized Controlled Trials
- (2011) Xiaojian Wu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- High-risk stage II colon cancer after curative resection
- (2011) Harunobu Sato et al. JOURNAL OF SURGICAL ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands
- (2009) L. N. van Steenbergen et al. ANNALS OF ONCOLOGY
- Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute
- (2009) Chun-Chi Lin et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
- (2008) Howard S. Hochster et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started